Navigation Links
Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
Date:3/9/2009

WEST PALM BEACH, Fla., March 9 /PRNewswire-FirstCall/ -- Explorations Group Inc. (OTC Bulletin Board: EXGI), announced today that it has signed a non-binding letter of intent to acquire Daniel R. Smith & Associates, Inc. ("DRSA"), a South Florida-based specialty lighting company for a total of $4.2 million to be paid in a combination of cash and debt. In announcing the Letter of Intent, EXGI President David Coriaty stated "the acquisition of DRSA is the next step in EXGI's plan to assemble a one stop solution for security, lighting and access control for the commercial, industrial and governmental markets by extending our product line to include DRSA's marine and industrial lighting solutions. Combined with our February 2009 acquisition of Hawk Biometric Technologies, we are now in position to offer a wide range of products for these markets."

The Boards of Directors of EXGI and DRSA have approved the transaction. EXGI expects to be able to promptly consummate the transaction, subject to due diligence, the execution of definitive agreements, and other conditions to closing. There is no assurance that a definitive agreement providing for the transaction as contemplated by the Letter of Intent will be executed or that the transaction will be consummated.

About EXGI - Explorations Group, Inc. is Florida-based provider of solutions of biometric security, access, lighting and control systems for industrial, commercial and governmental market. EXGI's recently acquired Hawk Biometric Technologies subsidiary is a developer of patented biometric systems for the automotive, real estate and maritime industries. Hawk Biometric's signature PASS(TM) product integrates fingerprint scanning into a vehicle's operating system and permits operation by only authorized drivers. Combined with optional GPS capabilities, PASS(TM) allows vehicle owners to remotely monitor, track, geo-fence, speed check and disable PASS(TM) equipped vehicles.

About DRSA - Formed in 1990, Daniel R. Smith & Associates, Inc. is a leading provider of lighting solutions for the marine and industrial markets.

Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the actual results of the Company to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "should," "intends," "will," or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports and registration statements filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Explorations Group Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. Explorations Group Acquires Hawk Biometric Technologies, Inc.
2. Titanium Group Announces Contract With Haitong Securities
3. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
4. Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar
5. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
6. UF botanists: Flowering plants evolved very quickly into 5 groups
7. Tree of life for flowering plants reveals relationships among major groups
8. Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong
9. Group selection, a theory whose time has come...again
10. Titanium Group Announces Launch of New Identification Solution Targeting High Growth Retail Sector
11. GestureTek/Imagination Launch AirPoint, Worlds First Hand-Tracking Unit, for Shell Group.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... general public,s help is being enlisted in what,s thought to be the ... the human body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest study to ... The project's goal is to help advance scientific knowledge of the role ... The ...
(Date:7/20/2017)... -- Delta (NYSE: DAL ) customers now can use fingerprints ... Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan Washington National ... Delta,s biometric boarding pass experience that launched ... into the boarding process to allow eligible Delta SkyMiles Members who are ...
(Date:6/23/2017)... N.Y. and ITHACA, N.Y. ... ) and Cornell University, a leader in dairy research, ... with bioinformatics designed to help reduce the chances that ... With the onset of this dairy project, Cornell University ... Consortium for Sequencing the Food Supply Chain, a food ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... Charlotte, N.C. (PRWEB) , ... October 11, 2017 ... ... ARCS® Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the ... Laboratories ( ASTER Labs ), Inc. has been selected for membership in ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
Breaking Biology Technology: